Immunohistochemical staining of commonly studied biomarkers in endometrial cancer window studies, including Ki-67, phosphorylated markers of key carcinogenic pathways and hormone receptors, is significantly lower in the hysterectomy specimen than in an endometrial biopsy taken immediately prior to surgery. This evidence concerns the gene NR4A1 and endometrial cancer.